Your browser doesn't support javascript.
loading
Amicrobial pustulosis of the folds: report of two cases / Pustulosis amicrobiana de los pliegues. Informe de dos casos
Escanilla-Figueroa, Claudio; Valenzuela-Ahumada, Fernando; Gatica-Monsalve, José Luis; Tabak-Cabrera, Denise; Barraza-Etcheverry, Camilo; Castillo-Pacheco, Douglas Del; Sazunic-Yáñez, Ivo.
  • Escanilla-Figueroa, Claudio; Hospital Barros Luco Trudeau. Department of Dermatology. Santiago. CL
  • Valenzuela-Ahumada, Fernando; University of Chile Clinical Hospital. Department of Dermatology. Santiago. CL
  • Gatica-Monsalve, José Luis; Clínica Orlandi. Santiago. CL
  • Tabak-Cabrera, Denise; Universidad de Santiago de Chile. Department of Dermatology. Santiago. CL
  • Barraza-Etcheverry, Camilo; University of Chile Clinical Hospital. Department of Dermatology. Santiago. CL
  • Castillo-Pacheco, Douglas Del; University of Chile Clinical Hospital. Department of Dermatology. Santiago. CL
  • Sazunic-Yáñez, Ivo; University of Chile. Faculty of Medicine. Department of Dermatology. Santiago. CL
Rev. méd. Chile ; 150(2): 256-260, feb. 2022. ilus
Article in English | LILACS | ID: biblio-1389633
ABSTRACT
ABSTRACT Amicrobial Pustulosis of the Folds is a relapsing, chronic and rare neutrophilic dermatosis, characterized by papulopustular, eczematous and aseptic lesions on skin folds. This disorder usually occurs predominantly in females (30 years of age average) with a history of an autoimmune disorder, especially systemic lupus erythematosus. There is no standard therapy, but systemic corticosteroids, alone or in combination with other immunosuppressive drugs, are usually the first-line therapy. We report two females aged 37 and 20 years with the disease but without associated autoimmune diseases. They were successfully treated with non-steroidal treatments.
RESUMEN
La pustulosis amicrobiana de los pliegues es una dermatosis neutrofílica crónica, recurrente y poco común. Se caracteriza por lesiones pápulo-pustulosas, eczematosas y asépticas de los pliegues cutáneos. Este cuadro se presenta predominantemente en mujeres de alrededor de 30 años con enfermedades autoinmunes, especialmente lupus eritematoso sistémico. No existe un tratamiento estándar pero los corticoides solos o con inmunosupresores se usan de primera línea. Informamos dos mujeres de 27 y 20 años sin patología autoinmune, con la enfermedad. Ellas fueron tratadas exitosamente sin usar esteroides.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Autoimmune Diseases / Lupus Erythematosus, Systemic Limits: Adult / Female / Humans Language: English Journal: Rev. méd. Chile Journal subject: Medicine Year: 2022 Type: Article Affiliation country: Chile Institution/Affiliation country: Clínica Orlandi/CL / Hospital Barros Luco Trudeau/CL / Universidad de Santiago de Chile/CL / University of Chile Clinical Hospital/CL / University of Chile/CL

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Autoimmune Diseases / Lupus Erythematosus, Systemic Limits: Adult / Female / Humans Language: English Journal: Rev. méd. Chile Journal subject: Medicine Year: 2022 Type: Article Affiliation country: Chile Institution/Affiliation country: Clínica Orlandi/CL / Hospital Barros Luco Trudeau/CL / Universidad de Santiago de Chile/CL / University of Chile Clinical Hospital/CL / University of Chile/CL